相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The immunogenicity of Bcr-Abl-expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl-regulated antigens
Florian Scheich et al.
BLOOD (2007)
BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells
Katharina M. Brauer et al.
CANCER RESEARCH (2007)
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines
Deepak P. Assudani et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Flow Cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of Superficial Transitional cell carcinoma of bladder
A Agarwal et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine
John Y. Kao et al.
IMMUNOLOGY LETTERS (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles
PK Chattopadhyay et al.
NATURE MEDICINE (2005)
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease
JP Uberti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Imatinib: the narrow line between immune tolerance and activation
M Mohty et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia:: Implications for vaccine development and adoptive cellular immunotherapy
M Gannagé et al.
JOURNAL OF IMMUNOLOGY (2005)
CD4 T cells in tumor immunity
M Gerloni et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate
J Cortes et al.
CLINICAL CANCER RESEARCH (2005)
Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance
HW Wang et al.
BLOOD (2005)
Tumor necrosis factor, cancer and anticancer therapy
S Mocellin et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Treatment options for chronic myelold leukemia: imatinib versus interferon versus allogeneic transplant
GR Angstreich et al.
CURRENT OPINION IN ONCOLOGY (2004)
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K Cathcart et al.
BLOOD (2004)
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells
S Appel et al.
BLOOD (2004)
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia
M Mohty et al.
BLOOD (2004)
Diversity and recognition efficiency of T cell responses to cancer
TB Stuge et al.
PLOS MEDICINE (2004)
Vaccination in humans generates broad T cell cytokine responses
SC De Rosa et al.
JOURNAL OF IMMUNOLOGY (2004)
The effects of STI571 on antigen presentation of dendritic cells generated from patients with chronic myelogenous leukemia
N Sato et al.
HEMATOLOGICAL ONCOLOGY (2003)
Ex vivo identification, isolation and analysis of tumor-cytolytic T cells
V Rubio et al.
NATURE MEDICINE (2003)
CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia
C Scheibenbogen et al.
BLOOD (2002)
Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP™ assay
U Prabhakar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)
分享论文
